Lupin launches generic diabetes drug in USLast Updated: October 03, 2025, 19:45 ISTRepresentational image (Image: News18)New Delhi, Oct 3 (PTI) Drug major Lupin on Friday said it has launched a generic diabetes medication in the US market. It has launched Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen, in the US, the Mumbai-based drug maker said in a statement. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with type 2 diabetes mellitus. “This marks a significant milestone in enhancing our portfolio of complex injectables and highlights our continued commitment to making essential therapies more accessible for patients," Lupin President – US Generics Spiro Gavaris said. PTI MSS MSS ANU ANUFirst Published: October 03, 2025, 19:45 ISTNews agency-feeds Lupin launches generic diabetes drug in USDisclaimer: Comments reflect users’ views, not News18’s.